CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-14 | Valle Franco Chief Financial Officer | Purchase | +10,000 | $8.68 | $87K | 10,000 |
| 2021-12-04 | Butler Thomas Andrew CEO | Grant or award · Stock Option (Right to Buy) | +305,400 | 305,400 | ||
| 2021-12-04 | Erdtmann Rainer M President & COO | Grant or award · Stock Option (Right to Buy) | +165,490 | 165,490 | ||
| 2021-12-04 | Valle Franco Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +144,770 | 144,770 | ||
| 2021-09-17 | A2A Pharmaceuticals, Inc. 10% owner | Purchase | +34,658 | $10.96 | $380K | 4,400,000 |
| 2021-09-17 | Stergiopoulos Sotirios Director | Purchase | +34,658 | $10.96 | $380K | 4,400,000 |
| 2021-08-23 | Erdtmann Rainer M President & COO | Purchase | +24,000 | $13.20 | $317K | 228,470 |
| 2021-08-23 | Butler Thomas Andrew CEO | Purchase | +24,000 | $13.20 | $317K | 228,470 |
| 2021-08-18 | Erdtmann Rainer M President & COO | Purchase | +14,000 | $10.77 | $151K | 204,470 |
| 2021-08-18 | Butler Thomas Andrew CEO | Purchase | +14,000 | $10.77 | $151K | 204,470 |
| 2021-08-17 | Erdtmann Rainer M President & COO | Purchase | +14,000 | $10.79 | $151K | 190,470 |
| 2021-08-17 | Butler Thomas Andrew CEO | Purchase | +14,000 | $10.79 | $151K | 190,470 |
| 2021-08-03 | Valle Franco Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2021-06-16 | Ray Sumita Director | Grant or award · Stock Option (Right to Buy) | +17,724 | 17,724 | ||
| 2021-04-20 | Chen Bihua Director | Conversion | +2,270,872 | 2,270,872 | ||
| 2021-04-20 | Chen Bihua Director | Purchase | +900,000 | $17.00 | $15.3M | 3,170,872 |
| 2021-04-20 | Chen Bihua Director | Conversion · Series A Convertible Preferred Stock | +2,270,872 | 0 | ||
| 2021-04-15 | Erdtmann Rainer M President and COO | Purchase | +2,400 | $17.00 | $41K | 2,400 |
| 2021-04-15 | Erdtmann Rainer M President and COO | Purchase | +3,000 | $17.00 | $51K | 3,000 |
| 2021-04-15 | Erdtmann Rainer M President and COO | Purchase | +3,000 | $17.00 | $51K | 3,000 |
Page 5 of 6 · 106 trades